Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sayaka Funabashi

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Atherosclerosis Plus|April 15, 2024
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.
Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
Atherosclerosis|May 8, 2025
The Brussels International Declaration on Lipoprotein(a) Testing and ManagementFlorian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Atherosclerosis Plus|April 15, 2024
Glucagon-like Peptide-1 analogues and delipidation of coronary atheroma in statin-treated type 2 diabetic patients with coronary artery disease: The prespecified sub-analysis of the OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Journal of Clinical Lipidology|January 21, 2026
Different response of plaque regression following achievement of LDL-C <1.8 mmol/L in obese and non-obese patients with diabetes and coronary artery disease: OPTIMAL sub-analysisAnthony Salib, Yu Kataoka, Stephen J Nicholls, et al.
Journal of Diabetes and Its Complications|September 23, 2023
The effect of continuous glucose monitoring-guided glycemic control on progression of coronary atherosclerosis in type 2 diabetic patients with coronary artery disease: The OPTIMAL randomized clinical trialYu Kataoka, Satoshi Kitahara, Sayaka Funabashi, et al.
Atherosclerosis|August 16, 2025
Apolipoprotein CIII in statin-treated type 2 diabetic patients: Its implications for plaque progression and instability: The pre-specified analysis from the OPTIMAL randomized controlled trialSatoshi Kitahara, Yu Kataoka, Stephen J Nicholls, et al.
Atherosclerosis|May 8, 2025
The Brussels International Declaration on Lipoprotein(a) Testing and ManagementFlorian Kronenberg, Nicola Bedlington, Zanfina Ademi, et al.
Pageof 3